SCHEMBL23267752

SCHEMBL23267752

C/C(O)=C(\C)c1cc(-c2c(C(C)C)cccc2C(C)C)c2cc([Si](C)(C)C)ccc2n1

nearest known ligand 0.32

Predicted protein targets (top 2)

geneUniProtsupporting neighboursconfidence
▸ LMNA P02545 1/20 0.32
▸ ACHE P22303 1/20 0.30

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL23267808 0.76 PTGFR (0.35) LMNA
SCHEMBL23268156 0.71 USP1 (0.35) LMNA
SCHEMBL23267809 0.68 AURKA (0.39) LMNA
SCHEMBL23268092 0.68 ALDH1A1 (0.36) LMNA
SCHEMBL23267788 0.67 GRM2 (0.33) —
SCHEMBL23268389 0.66 ALDH1A1 (0.39) LMNA
SCHEMBL23267807 0.65 ALDH1A1 (0.38) LMNA
SCHEMBL23241891 0.60 ALDH1A1 (0.57) LMNAACHE
SCHEMBL23267810 0.59 ALDH1A1 (0.46) LMNA
SCHEMBL10673224 0.58 ANPEP (0.51) LMNA

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20210115077-A1 Organometallic compound, organic light-emitting device including the same, and diagnosing composition including the organometallic compound SAMSUNG ELECTRONICS CO., LTD. (KR) 2021-04-22 — — US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20210115077-A1 Organometallic compound, organic light-emitting device including the same, and diagnosing composition including the organometallic compound L1CAM, MSL1, NOM1 LMNA 1101/4885ACHE 1487/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.

Send feedback